|
 |
 |
|
|
|
Professor Erik Sontheimer (co-founder of SilenTech) presents potential business opportunities for RNAi technology development from his laboratory |
|
 |
|
|
|
Professor SonBinh Nguyen discusses opportunities for polymer encased drug delivery.
|
|
 |
|
|
|
Professor Guillermo Ameer presents biological implants that are more easily integrated by tissues and bones.
|
|
|
Academic exploration in the field of nanotechnology is often driven by federal and state investment, with the hope that this investment will bear fruit in the marketplace.
The IIN's Small Business Entrepreneur's Evaluation (SBEE) program provides a platform for scientists and engineers to present their newly developed technologies and receive assistance in the development of viable business plans.
Each quarter, faculty members are offered the opportunity to present their marketable technology to an audience ofstudents from the NU Kellogg School of Management, who then may use this as a springboard for writing a complete business plan. The success of the SBEE program, headed by Professors Barry Merkin and Chad Mirkin, is evidence by the formulation of 11 start-up companies since 2002.
|
- Developing the first effective therapeutics and diagnostics for Alzheimer's disease and other memory-related disorders
|
|
- Rapid prototyping of bioMEMS and polymer MEMS
|
Nanocore |
- Commercializing process for making bulk scale quantities of nanoprisms
|
|
- Enabling the biochemistry of membrane-associated molecules for drug discovery and novel therapeutic applications
|
|
- Commercializes Dip-pen Nanolithography and develops products in the life science and electronics industries
|
|
- Supplies single-walled carbon nanotubes with uniform diameter and/or electronic type
|
NanoSense |
- Offers a solution to the industry problem of finding small yet critical microchip defects that are buried underneath the surface
|
|
- Develops commercial diagnostic systems that use nanoparticles to detect disease targets ranging from HIV to methicillin-resistant bacteria
|
|
- Utilizes self-assembling amphiphilic molecules to enable tissue regeneration
|
|
- Produces point-of-care electronic pathogen detection devices
|
|
- Supplier of materials technology for the printed electronics industry
|
|
- Improvement of RNAi efficacy by blocking RNAi inhibitors
|
During the 2006 fall quarter, the following presentations were given (click title to read the SBEE proposal):
|
|
